Neuronal mitochondria-targeted therapy for Alzheimer’s disease by systemic delivery of resveratrol using dual-modified novel biomimetic nanosystems

References

• Anniss AM, Sparrow RL. (2002). Expression of CD47 (integrin-associated protein) decreases on red-blood cells during storage. Transfus Apher Sci 27:233–8.
   PubMed Web of Science ®Google Scholar
• Asai H, Ikezu S, Tsunoda S, et al. (2015). Depletion of microglia and inhibition of exosome synthesis halt tau propagation. Nat Neurosci 18:1584–93.
   PubMed Web of Science ®Google Scholar
• Ballard C, Gauthier S, Corbett A, et al. (2011). Alzheimer’s disease. Lancet 377:1019–31.
   PubMed Web of Science ®Google Scholar
• Biswas S, Dodwadkar NS, Deshpande PP, Torchilin VP. (2012). Liposomes loaded with paclitaxel and modified with novel triphenylphosphonium-PEG-PE conjugate possess low toxicity, target mitochondria and demonstrate enhanced antitumor effects in vitro and in vivo. J Control Release 159:393–402.
   PubMed Web of Science ®Google Scholar
• Caldwell CC, Yao J, Brinton RD. (2015). Targeting the prodromal stage of Alzheimer’s disease: bioenergetic and mitochondrial opportunities. Neurotherapeutics 12:66–80.
   PubMed Web of Science ®Google Scholar
• Careri M, Corradini C, Elviri L, et al. (2003). Direct HPLC analysis of quercetin and trans-resveratrol in red wine, grape, and winemaking byproducts. J Agric Food Chem 51:5226–31.
   PubMed Web of Science ®Google Scholar
• Celia C, Trapasso E, Cosco D, et al. (2009). Turbiscan lab (R) expert analysis of the stability of ethosomes (R) and ultradeformable liposomes containing a bilayer fluidizing agent. Colloid Surface B 72:155–60.
   PubMed Web of Science ®Google Scholar
• Chai ZL, Ran DN, Lu LW, et al. (2019). Ligand-modified cell membrane enables the targeted delivery of drug nanocrystals to glioma. Acs Nano 13:5591–601.
   PubMed Web of Science ®Google Scholar
• Cui GH, Guo HD, Li H, et al. (2019). RVG-modified exosomes derived from mesenchymal stem cells rescue memory deficits by regulating inflammatory responses in a mouse model of Alzheimer’s disease. Immun Ageing 16:10.
   PubMed Web of Science ®Google Scholar
• Dodge JT, Hanahan DJ, Mitchell C. (1963). Preparation and chemical characteristics of hemoglobin-free ghosts of human erythrocytes. Arch Biochem Biophys 100:119–30.
   PubMed Web of Science ®Google Scholar
• Doody RS, Raman R, Farlow M, et al. (2013). A phase 3 trial of semagacestat for treatment of Alzheimer’s disease. N Engl J Med 369:341–50.
   PubMed Web of Science ®Google Scholar
• Doody RS, Thomas RG, Farlow M, et al. (2014). Phase 3 trials of solanezumab for mild-to-moderate Alzheimer’s disease. N Engl J Med 370:311–21.
   PubMed Web of Science ®Google Scholar
• Fang RNH, Hu CMJ, Chen KNH, et al. (2013). Lipid-insertion enables targeting functionalization of erythrocyte membrane-cloaked nanoparticles. Nanoscale 5:8884–8.
   PubMed Web of Science ®Google Scholar
• Fang RH, Jiang Y, Fang JC, Zhang LF. (2017). Cell membrane-derived nanomaterials for biomedical applications. Biomaterials 128:69–83.
   PubMed Web of Science ®Google Scholar
• Fu SY, Liang M, Wang YL, Cui L, et al. (2019). Dual-modified novel biomimetic nanocarriers improve targeting and therapeutic efficacy in glioma. ACS Appl Mater Interfaces 11:1841–54.
   PubMed Web of Science ®Google Scholar
• Fuhrmann T, Ghosh M, Otero A, et al. (2015). Peptide-functionalized polymeric nanoparticles for active targeting of damaged tissue in animals with experimental autoimmune encephalomyelitis. Neurosci Lett 602:126–32.
   PubMed Web of Science ®Google Scholar
• Hardy J, Allsop D. (1991). Amyloid deposition as the central event in the etiology of alzheimers-disease. Trends Pharmacol Sci 12:383–8.
   PubMed Web of Science ®Google Scholar
• He H, Chen XJ, Wang GJ, et al. (2006). High-performance liquid chromatography spectrometric analysis of trans-resveratrol in rat plasma. J Chromatogr B 832:177–80.
   PubMed Web of Science ®Google Scholar
• Jack CR, Knopman DS, Chetelat G, et al. (2016). Suspected non-Alzheimer disease pathophysiology - concept and controversy. Nat Rev Neurol 12:117–24.
   PubMed Web of Science ®Google Scholar
• Jin J, Shi F, Li QW, et al. (2016). Evaluation of free radical scavenging capacity and antioxidative damage effect of resveratrol-nanostructured lipid carriers. Proc Spie 9722, Colloidal Nanoparticles for Biomedical Applications XI, 97221D; 2016 April 22.
   Google Scholar
• Kerr JS, Adriaanse BA, Greig NH, et al. (2017). Mitophagy and Alzheimer’s disease: cellular and molecular mechanisms. Trends Neurosci 40:151–66.
   PubMed Web of Science ®Google Scholar
• Khanduja KL, Bhardwaj A. (2003). Stable free radical scavenging and antiperoxidative properties of resveratrol compared in vitro with some other bioflavonoids. Indian J Biochem Bio 40:416–22.
   PubMed Web of Science ®Google Scholar
• Kwon HJ, Cha MY, Kim D, Kim DK, et al. (2016). Mitochondria-targeting ceria nanoparticles as antioxidants for Alzheimer’s disease. ACS Nano 10:2860–70.
   PubMed Web of Science ®Google Scholar
• Lin MT, Beal MF. (2006). Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases. Nature 443:787–95.
   PubMed Web of Science ®Google Scholar
• Lovell MA, Xiong SL, Xie CS, et al. (2005). Induction of hyperphosphorylated tau in primary rat cortical neuron cultures mediated by oxidative stress and glycogen synthase kinase-3. JAD 6:659–71.
   Google Scholar
• Marrache S, Dhar S. (2012). Engineering of blended nanoparticle platform for delivery of mitochondria-acting therapeutics. Proc Natl Acad Sci USA 109:16288–93.
   PubMed Web of Science ®Google Scholar
• Mhatre SD, Tsai CA, Rubin AJ, et al. (2015). Microglial malfunction: the third rail in the development of Alzheimer’s disease. Trends Neurosci 38:621–36.
   PubMed Web of Science ®Google Scholar
• Omidi Y, Campbell L, Barar J, et al. (2003). Evaluation of the immortalised mouse brain capillary endothelial cell line, b.End3, as an in vitro blood–brain barrier model for drug uptake and transport studies. Brain Res 990:95–112.
   PubMed Web of Science ®Google Scholar
• Park TE, Singh B, Li H, et al. (2015). Enhanced BBB permeability of osmotically active poly(mannitol-co-PEI) modified with rabies virus glycoprotein via selective stimulation of caveolar endocytosis for RNAi therapeutics in Alzheimer’s disease. Biomaterials 38:61–71.
   PubMed Web of Science ®Google Scholar
• Salloway S, Sperling R, Fox NC, et al. (2014). Two phase 3 trials of bapineuzumab in mild-to-moderate Alzheimer’s disease. N Engl J Med 370:322–33.
   PubMed Web of Science ®Google Scholar
• Sawda C, Moussa C, Turner RS. (2017). Resveratrol for Alzheimer’s disease. Ann NY Acad Sci 1403:142–9.
   PubMed Web of Science ®Google Scholar
• Schonhegrad MA, Holt PG. (1981). Improved method for the isolation of purified mouse peritoneal-macrophages. J Immunol Methods 43:169–73.
   PubMed Web of Science ®Google Scholar
• Selfridge JE, E LZ, Lu JH, Swerdlow RH. (2013). Role of mitochondrial homeostasis and dynamics in Alzheimer’s disease. Neurobiol Dis 51:3–12.
   PubMed Web of Science ®Google Scholar
• Shafiei SS, Guerrero-Munoz MJ, Castillo-Carranza DL. (2017). Tau oligomers: cytotoxicity, propagation, and mitochondrial damage. Front Aging Neurosci 9:83.
   PubMed Web of Science ®Google Scholar
• Singh M, Arseneault M, Sanderson T, et al. (2008). Challenges for research on polyphenols from foods in Alzheimer’s disease: bioavailability, metabolism, and cellular and molecular mechanisms. J Agric Food Chem 56:4855–73.
   PubMed Web of Science ®Google Scholar
• Swerdlow RH, Khan SM. (2004). A “mitochondrial cascade hypthesis” for sporadic Alzheimer’s disease. Med Hypotheses 63:8–20.
   PubMed Web of Science ®Google Scholar
• Tang XQ, Luo YX, Chen HZ, Liu DP. (2014). Mitochondria, endothelial cell function, and vascular diseases. Front Physiol 5:175.
   PubMed Web of Science ®Google Scholar
• Verdin E, Hirschey MD, Finley LWS, Haigis MC. (2010). Sirtuin regulation of mitochondria: energy production, apoptosis, and signaling. Trends Biochem Sci 35:669–75.
   PubMed Web of Science ®Google Scholar
• Walle T, Hsieh F, DeLegge MH, et al. (2004). High absorption but very low bioavailability of oral resveratrol in humans. Drug Metab Dispos 32:1377–82.
   PubMed Web of Science ®Google Scholar
• Wang Y, Catana F, Yang YN, et al. (2002). An LC-MS method for analyzing total resveratrol in grape juice, cranberry juice, and in wine. J Agric Food Chem 50:431–5.
   PubMed Web of Science ®Google Scholar
• Wang J, Chen GJ. (2016). Mitochondria as a therapeutic target in Alzheimer’s disease. Genes Dis 3:220–7.
   PubMed Web of Science ®Google Scholar
• Wang Q, Liu TT, Fu Y, et al. (2010). Vanadium compounds discriminate hepatoma and normal hepatic cells by differential regulation of reactive oxygen species. J Biol Inorg Chem 15:1087–97.
   PubMed Web of Science ®Google Scholar
• Wang Y, Wang N, Cai B, et al. (2015). In vitro model of the blood–brain barrier established by co-culture of primary cerebral microvascular endothelial and astrocyte cells. Neural Regen Res 10:2011–7.
   PubMed Web of Science ®Google Scholar
• Yang H. (2010). Nanoparticle-mediated brain-specific drug delivery, imaging, and diagnosis. Pharm Res 27:1759–71.
   PubMed Web of Science ®Google Scholar
• Yao L, Gu X, Song QX, et al. (2016). Nanoformulated alpha-mangostin ameliorates Alzheimer’s disease neuropathology by elevating LDLR expression and accelerating amyloid-beta clearance. J Control Release 226:1–14.
   PubMed Web of Science ®Google Scholar
• Yao J, Irwin RW, Zhao LQ, et al. (2009). Mitochondrial bioenergetic deficit precedes Alzheimer’s pathology in female mouse model of Alzheimer’s disease. Proc Natl Acad Sci USA 106:14670–5.
   PubMed Web of Science ®Google Scholar
• Yun J, Finkel T. (2014). Mitohormesis. Cell Metab 19:757–66.
   PubMed Web of Science ®Google Scholar
• Zhang GL, Zhang WG, Du Y, et al. (2013). Edaravone ameliorates oxidative damage associated with a beta 25-35 treatment in PC12 cells. J Mol Neurosci 50:494–503.
   PubMed Web of Science ®Google Scholar
• Zhao ZX, Gao SY, Wang JC, et al. (2012). Self-assembly nanomicelles based on cationic mPEG-PLA-b-polyarginine(R-15) triblock copolymer for siRNA delivery. Biomaterials 33:6793–807.
   PubMed Web of Science ®Google Scholar